Adverse drug events in the elderly can be prevented with appropriate monitoring, according to CDC.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
FDA Approves Eydenzelt, Additional Eylea Biosimilar
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
Novartis to Offer Cosentyx to Cash Paying Patients at a 55% Discount
Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes
FDA Approves Extended Indication for Evkeeza
AstraZeneca to Offer Airsupra Direct to Patient